Selective Estrogen Receptor Modulators

@article{Haskell2003SelectiveER,
  title={Selective Estrogen Receptor Modulators},
  author={S. Haskell},
  journal={Southern Medical Journal},
  year={2003},
  volume={96},
  pages={469-476}
}
  • S. Haskell
  • Published 2003
  • Medicine
  • Southern Medical Journal
Because of recent concerns about the long-term risks of estrogen replacement therapy in postmenopausal women, there is growing interest in a group of compounds known as selective estrogen receptor modulators (SERMs). The SERMs bind to estrogen receptors and have tissue-specific effects that allow them to function as estrogen agonists in some tissues and estrogen antagonists in other tissues. There are four SERMs currently marketed in the United States. These include the triphenylethylenes… Expand
17 Citations
[Changes in the endometrium after tamoxifen therapy].
  • 3
[Effects of tamoxifen on the expression of TGF-beta and p27 proteins in polyps and adjacent endometrium in postmenopausal women].
  • Highly Influenced
  • PDF
Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling
  • 23
...
1
2
...

References

SHOWING 1-10 OF 102 REFERENCES
Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women.
  • 56
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
  • 690
  • PDF
The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal postmenopausal women.
  • 136
Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
  • 140
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.
  • 1,098
...
1
2
3
4
5
...